Last reviewed · How we verify
NCT06853275
The Influence of Movement Velocity Biofeedback on Muscle Activation and Self Perception in Older Adults With Sarcopenia
NA trial testing Experimental: External Focus in Sarcopenia in 60 participants. Currently enrolling.
31 December 2027
Quick facts
| Lead sponsor | Creighton University |
|---|---|
| Phase | NA |
| Status | Recruiting now |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | crossover |
| Masking | none |
| Primary purpose | basic science |
| Enrollment | 60 |
| Start date | 1 August 2025 |
| Primary completion | 31 December 2027 |
| Estimated completion | 31 December 2027 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Experimental: External Focus
- Other: Internal Focus
Conditions studied
- Sarcopenia — all drugs for Sarcopenia →
- Sarcopenia in Elderly — all drugs for Sarcopenia in Elderly →
- Age-associated Muscle Loss — all drugs for Age-associated Muscle Loss →
Sponsor
Creighton University
Who can join
Adults 60 to 95, any sex, with Sarcopenia or Sarcopenia in Elderly. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The overall objective for this clinical trial is to provide evidence for internal and external cueing for physical therapists and other rehabilitation clinicians to optimize resistance training within rehabilitation for older adults. The main questions it aims to answer are: * What is the impact of external focus (providing velocity of movement for each repetition) compared to internal focus (i.e., no cues, control group) on physical percent velocity loss and neuromuscular activation in older adults with sarcopenia? * Does internal and external focus influence motivation and perceptual workload following resistance training in older adults with sarcopenia? Researchers will compare external focus to internal focus to see if external focus impacts percent velocity loss, motivation, and perceived workload. Participants will: * Visit the lab once per week for 3 weeks * Perform exercise testing using a leg press * Answer questionnaires regarding perceived workload and motivation before and after exercise
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06853275
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Sarcopenia
Currently open trials in the same condition.
- NCT07500376 — Multimodal Nutritional and Sarcopenia Assessment for Risk Stratification in Lung Cancer Surgery · recruiting
- NCT07456956 — HIIT vs MCIT for Stroke-Related Sarcopenia in Ischemic Stroke · NA · recruiting
- NCT07398495 — Multimodal Training Effects in Middle-Aged and Older Adults With Diabetic Sarcopenia · NA · recruiting
- NCT07494916 — Effects of Functional Task Training on Muscle Health and Function in Older Adults With Sarcopenia · NA · active not recruiting
- NCT07426159 — AI-Guided Sarcopenia Risk Assessment and Detection · NA · active not recruiting
Other Creighton University trials
Trials by the same sponsor.
- NCT06732440 — Subthreshold Vestibular Stimulation as a Strategy for Rehabilitation · NA · recruiting
- NCT07171255 — Improving Exercise Adherence With App Technology for At-Risk Adults Living in Rural Kansas and Nebraska · NA · recruiting
- NCT06976060 — High-Intensity Interval Training in a Community Gym · NA · completed
- NCT07237581 — Cognitive Behavioral Based Physical Therapy for Patients With Chronic Ankle Instability · NA · completed
- NCT05370118 — Improving Physical Activity With Cognitive Impairment · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06853275 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Creighton University
- Last refreshed: 18 March 2026
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06853275.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing